Isfahan University of Medical Sciences

Science Communicator Platform

Share By
Chitin and Chitosan As Tools to Combat Covid-19: A Triple Approach Publisher Pubmed



Safarzadeh M1 ; Sadeghi S2 ; Azizi M3 ; Rastegaripouyani M1 ; Pouriran R4 ; Haji Molla Hoseini M5, 6
Authors

Source: International Journal of Biological Macromolecules Published:2021


Abstract

The progressive and fatal outbreak of the newly emerged coronavirus, SARS-CoV-2, necessitates rigorous collaboration of all health care systems and researchers from all around the world to bring such a devastating pandemic under control. As there is so far no officially approved drug or ideal vaccine for this disease, investigations on this infectious disease are actively pursued. Chitin and chitosan have shown promising results against viral infections. In this review, we first delve into the problematic consequences of viral pandemics followed by an introduction on SARS-CoV-2 taxonomical classification. Then, we elaborate on the immunology of COVID-19. Common antiviral therapies and their related limitations are described and finally, the potential applicability of chitin and chitosan to fight this overwhelming viral pandemic is addressed. © 2021
Related Docs
View other Related Docs
1. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
2. The Direct and Indirect Effects of Bioactive Compounds Against Coronavirus, Food Frontiers (2022)
3. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
Experts (# of related papers)
View all Related Experts
Shahrzad Ahangarzadeh (2)
Ghazaleh Jamalipour Soufi (2)
Other Related Docs
4. Emerging Technologies for the Treatment of Covid-19, Advances in Experimental Medicine and Biology (2021)
5. Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of Covid.19 Pandemic: A Narrative Review, International Journal of Preventive Medicine (2021)
6. Potential Inhibitors of Sars-Cov-2: Recent Advances, Journal of Drug Targeting (2021)
7. Nanomaterials and Nanotechnology-Associated Innovations Against Viral Infections With a Focus on Coronaviruses, Nanomaterials (2020)
8. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
9. Cardiovascular Complications of Sars-Cov-2 Vaccines: An Overview, Cardiology and Therapy (2022)
10. Immune and Bioinformatics Identification of T Cell and B Cell Epitopes in the Protein Structure of Sars-Cov-2: A Systematic Review, International Immunopharmacology (2020)
11. An Update on Antiviral Antibody-Based Biopharmaceuticals, International Immunopharmacology (2020)
12. Nanobased Platforms for Diagnosis and Treatment of Covid-19: From Benchtop to Bedside, ACS Biomaterials Science and Engineering (2021)
13. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)
14. Genetics and Genomics of Sars-Cov-2: A Review of the Literature With the Special Focus on Genetic Diversity and Sars-Cov-2 Genome Detection, Genomics (2021)
15. Exploring the Out of Sight Antigens of Sars-Cov-2 to Design a Candidate Multi-Epitope Vaccine by Utilizing Immunoinformatics Approaches, Vaccine (2020)
16. Potential Treatments for Covid-19; a Narrative Literature Review, Archives of Academic Emergency Medicine (2020)
17. Nanostructures for Prevention, Diagnosis, and Treatment of Viral Respiratory Infections: From Influenza Virus to Sars-Cov-2 Variants, Journal of Nanobiotechnology (2023)
18. Association of Prior Covid‑19 Infection With Risk of Breakthrough Infection Following Vaccination: A Cohort Study in Isfahan, Iran, International Journal of Preventive Medicine (2024)
19. Covid-19 Management in the Emergency Ward, Journal of Research in Medical Sciences (2021)
20. Human Respiratory Syncytial Virus and Coronavirus Rates in Iranian Elderly Patients More Than 60 Years Old With Acute Respiratory Symptoms, Advanced Biomedical Research (2023)